Novel transcript, antisense to Mitogen-activated protein kinase kinase kinase 2 (ENSG00000286145)

This molecule is a **non-coding RNA transcript** transcribed in the antisense direction of the MAP3K2 gene locus. Antisense transcripts can regulate the expression of their sense counterpart genes through mechanisms such as **transcriptional interference, RNA duplex formation, or modification of chromatin state**[1]. Currently, there is no experimental evidence that this particular antisense transcript is a therapeutic target, nor is there established information regarding disease associations, drug interactions, or biomarker use for this entity. The protein-coding gene MAP3K2, which encodes a kinase involved in signal transduction and is associated with cancer, is distinct from this non-coding antisense transcript[3]. The biological function and significance of the ENSG00000286145 antisense transcript remain largely uncharacterized. If you require information specifically on the protein-coding gene MAP3K2 as a target, please specify, as that represents a different molecule with a well-established profile in oncology and signal transduction.

Other names

antisense RNA to MAP3K2antisense to Mitogen-activated protein kinase kinase kinase 2